Admin Core
管理核心
基本信息
- 批准号:10407555
- 负责人:
- 金额:$ 17.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-08-01 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AdherenceAuthorization documentationCell CommunicationCellsDataDiabetes MellitusEnsureGoalsGuidelinesMaintenanceOccupational activity of managing financesRegulationReproducibilityResearchResearch PersonnelScheduleSignal TransductionSupervisionUniversitiescohesionischemic injurymacrophagemeetingsmemberprograms
项目摘要
Project Summary: ADMIN Core
The broad goals of the Administrative Core are to serve as a cohesive unit for the Program Project team in order
to cement their interactions with each other, with the subcontract investigators and the Internal and External
Advisory boards. This Core will see to meticulous financial management of the Program Project; strict adherence
to all University guidelines and research regulations; and to the scheduling of regular meetings of the entire
Program Project to ensure rigor, transparency and reproducibility of the data. Aim 1 will provide supervision of
program finances, administrative and secretarial support, maintenance of authorizations and adherence to
institutional requirements, and coordination of the Subcontracts to the University of Albany and to Columbia
University. Aim 2 will coordinate meetings and videoconferences of the Program Project team, including the
Project Leaders, Core Leaders, all scientific and technical staff at NYU and the University of Albany, and all of
the members of the subcontract teams. Finally, Aim 3 will coordinate meetings of the Internal and External
Advisory Boards for the Program Project. The Administrative Core serves all three Projects and Core 2 over the
five years of the Program Project.
项目概要:ADMIN Core
行政核心的主要目标是作为计划项目团队的一个有凝聚力的单位,
加强他们之间的互动,与调查人员和内部和外部
咨询委员会。该核心将确保对计划项目进行细致的财务管理;严格遵守
所有大学的指导方针和研究条例;以及整个定期会议的安排
程序项目,以确保数据的严谨性,透明度和可重复性。目标1将提供以下监督:
计划财务、行政和秘书支持、授权维护和遵守
机构要求,以及与奥尔巴尼大学和哥伦比亚大学分包合同的协调
大学目标2将协调方案项目小组的会议和视频会议,包括
项目负责人,核心领导人,纽约大学和奥尔巴尼大学的所有科学和技术人员,以及
的成员。最后,目标3将协调内部和外部会议,
项目咨询委员会。行政核心服务于所有三个项目,核心2服务于
五年的计划。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANN MARIE SCHMIDT其他文献
ANN MARIE SCHMIDT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANN MARIE SCHMIDT', 18)}}的其他基金
Macrophages, Cell-Cell Communication, Ischemic Injury in Diabetes and the RAGE/DIAPH1 Signaling Axis
巨噬细胞、细胞间通讯、糖尿病缺血性损伤和 RAGE/DIAPH1 信号轴
- 批准号:
10191018 - 财政年份:2019
- 资助金额:
$ 17.49万 - 项目类别:
Project 2: Diabetes, RAGE/DIAPH1 and Hind Limb Ischemia
项目2:糖尿病、RAGE/DIAPH1 和后肢缺血
- 批准号:
10191022 - 财政年份:2019
- 资助金额:
$ 17.49万 - 项目类别:
Macrophages, Cell-Cell Communication, Ischemic Injury in Diabetes and the RAGE/DIAPH1 Signaling Axis
巨噬细胞、细胞间通讯、糖尿病缺血性损伤和 RAGE/DIAPH1 信号轴
- 批准号:
10407554 - 财政年份:2019
- 资助金额:
$ 17.49万 - 项目类别:
Project 2: Diabetes, RAGE/DIAPH1 and Hind Limb Ischemia
项目2:糖尿病、RAGE/DIAPH1 和后肢缺血
- 批准号:
10407558 - 财政年份:2019
- 资助金额:
$ 17.49万 - 项目类别:
Macrophages, Cell-Cell Communication, Ischemic Injury in Diabetes and the RAGE/DIAPH1 Signaling Axis
巨噬细胞、细胞间通讯、糖尿病缺血性损伤和 RAGE/DIAPH1 信号轴
- 批准号:
10642704 - 财政年份:2019
- 资助金额:
$ 17.49万 - 项目类别:
Project 2: Diabetes, RAGE/DIAPH1 and Hind Limb Ischemia
项目2:糖尿病、RAGE/DIAPH1 和后肢缺血
- 批准号:
10642712 - 财政年份:2019
- 资助金额:
$ 17.49万 - 项目类别:
RAGE, DIAPH1 and IRF7 and Macrophage Dysfunction in Atherosclerosis and Cardiometabolic Disease
动脉粥样硬化和心脏代谢疾病中的 RAGE、DIAPH1 和 IRF7 以及巨噬细胞功能障碍
- 批准号:
10424906 - 财政年份:2017
- 资助金额:
$ 17.49万 - 项目类别:
相似海外基金
OncoPath: Intelligent Clinical Pathway Decision Support Tool for Pre-Authorization Documentation in Non-Small Cell Lung Cancer Treatment
OncoPath:用于非小细胞肺癌治疗预授权文档的智能临床路径决策支持工具
- 批准号:
10325551 - 财政年份:2021
- 资助金额:
$ 17.49万 - 项目类别:














{{item.name}}会员




